Combat veterans of the Global War on Terror (GWOT), including missions in Iraq and Afghanistan, are facing a disturbingly high incidence of cancer, likened to the legacy of Agent Orange among Vietnam War veterans.
The death of Alan Yoshida, a combat controller who served in Afghanistan, underscores a broader, alarming trend: a significant number of GWOT veterans are being diagnosed with cancer at rates that challenge the mortality figures from combat itself. This issue, while critical, has not garnered the widespread attention or action necessary to support the affected veterans adequately.
Read the full story at Defense One
